Substituted 1,2,3,4tetrahydrocyclopenta[b]indol-3-yl) acetic acid derivatives useful in the treatment of autoimmune and inflammatory disorders

Details for Australian Patent Application No. 2009274569 (hide)

Owner Arena Pharmaceuticals, Inc.

Inventors Jones, Robert M.; Buzard, Daniel J.; Han, Sangdon; Kim, Sun He; Lehmann, Juerg; Ullman, Brett; Moody, Jeanne V.; Zhu, Xiuwen; Stirn, Scott

Agent FB Rice

Pub. Number AU-A-2009274569

PCT Pub. Number WO2010/011316

Priority 61/135,672 23.07.08 US; 61/209,374 06.03.09 US

Filing date 22 July 2009

Wipo publication date 28 January 2010

International Classifications

C07D 209/70 (2006.01) Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom

A61K 31/403 (2006.01) - condensed with carbocyclic rings, e.g. carbazole

A61P 37/00 (2006.01) Drugs for immunological or allergic disorders

C07D 209/88 (2006.01) Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom

C07D 401/12 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 403/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 417/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

Event Publications

3 February 2011 PCT application entered the National Phase

  PCT publication WO2010/011316 Priority application(s): WO2010/011316

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009274571-Activatiqn of histone deacetylase 1 (HDAC1) protects against DNA damage and increases neuronal survival

2009274568-Proteins for use in diagnosing and treating infection and disease